Article
Methotrexate pharmacogenetics in Uruguayan adults with hematological malignant diseases.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences - 15 Nov 2017
Giletti Andrea, Vital Marcelo, Lorenzo Mariana, Cardozo Patricia, Borelli Gabriel, Gabus Raúl, Martínez Lem, Díaz Lilian, Assar Rodrigo, Rodriguez María Noel, Esperón Patricia
Abstract excerpt
BACKGROUND: Individual variability is among the causes of toxicity and interruption of treatment in acute lymphoblastic leukemia (ALL) and severe non-Hodgkin lymphoma (NHL) patients under protocols including Methotrexate (MTX): 2,4-diamino-N10-methyl propyl-glutamic acid. METHODS: 41 Uruguayan patients were recruited. Gene polymorphisms involved in MTX pathway were analyzed and their association with treatment...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
